IMM 6.33% 42.0¢ immutep limited

ASCO Poster Presentation, page-2

  1. 742 Posts.
    lightbulb Created with Sketch. 123
    Thanks for posting bigdish

    CONCLUSIONS

    30 mg IMP321 is the RPDT in combination with weekly paclitaxel as a first line chemotherapy treatment of MBC.

    6 and 30 mg IMP321 are safe and well tolerated in combination with weekly paclitaxel

    IMP321 in combination with paclitaxel shows encouraging DCR (87%)

    IMP321 leads to sustainable (> 6months) increase and activation of APC’s (primary PD)

    IMP321 leads to sustainable (> 6months) increase in CD8 T Cell and NK cell numbers, together with an improved pre-dose Th1 status ( secondary PD).

    This should get the party started. Good luck to all.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
0.025(6.33%)
Mkt cap ! $598.3M
Open High Low Value Volume
39.5¢ 42.0¢ 39.5¢ $890.1K 2.163M

Buyers (Bids)

No. Vol. Price($)
3 127863 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 30850 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.